Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

We are currently facing an issue in receiving the NSE feed. Hence the stock prices are not updated. We are working on fixing this at the earliest. We regret the inconvenience caused.

MANGALORE CHEMICALS 2022-23 Annual Report Analysis
Thu, 28 Sep

MANGALORE CHEMICALS has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

MANGALORE CHEMICALS Income Statement Analysis

  • Operating income during the year rose 25.8% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 47.1% YoY during the fiscal. Operating profit margins witnessed a fall and down at 8.5% in FY23 as against 7.3% in FY22.
  • Depreciation charges increased by 18.0% and finance costs increased by 111.3% YoY, respectively.
  • Other income grew by 26.3% YoY.
  • Net profit for the year grew by 53.3% YoY.
  • Net profit margins during the year grew from 3.0% in FY22 to 3.7% in FY23.

MANGALORE CHEMICALS Income Statement 2022-23

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Net Sales Rs m 28,956 36,415 25.8%
Other income Rs m 243 306 26.3%
Total Revenues Rs m 29,199 36,722 25.8%
Gross profit Rs m 2,104 3,094 47.1%
Depreciation Rs m 506 597 18.0%
Interest Rs m 494 1,044 111.3%
Profit before tax Rs m 1,347 1,760 30.7%
Tax Rs m 468 414 -11.6%
Profit after tax Rs m 879 1,347 53.3%
Gross profit margin % 7.3 8.5
Effective tax rate % 34.8 23.5
Net profit margin % 3.0 3.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



RESPONSE PENDING: Your Meeting with Tanushree Banerjee Tomorrow...

MANGALORE CHEMICALS Balance Sheet Analysis

  • The company's current liabilities during FY23 down at Rs 14 billion as compared to Rs 17 billion in FY22, thereby witnessing an decrease of -19.0%.
  • Long-term debt stood at Rs 4 billion as compared to Rs 2 billion during FY22, a growth of 63.5%.
  • Current assets fell 14% and stood at Rs 16 billion, while fixed assets rose 21% and stood at Rs 11 billion in FY23.
  • Overall, the total assets and liabilities for FY23 stood at Rs 27 billion as against Rs 27 billion during FY22, thereby witnessing a fall of 2%.

MANGALORE CHEMICALS Balance Sheet as on March 2023

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Networth Rs m 6,831 8,032 17.6
 
Current Liabilities Rs m 17,363 14,071 -19.0
Long-term Debt Rs m 2,182 3,567 63.5
Total Liabilities Rs m 27,208 26,592 -2.3
 
Current assets Rs m 18,099 15,544 -14.1
Fixed Assets Rs m 9,109 11,047 21.3
Total Assets Rs m 27,208 26,592 -2.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



MANGALORE CHEMICALS Cash Flow Statement Analysis

  • MANGALORE CHEMICALS's cash flow from operating activities (CFO) during FY23 stood at Rs 2 billion on a YoY basis.
  • Cash flow from investing activities (CFI) during FY23 stood at Rs -2 billion, an improvement of 30.0% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY23 stood at Rs -1 billion on a YoY basis.
  • Overall, net cash flows for the company during FY23 stood at Rs -2 billion from the Rs 1 billion net cash flows seen during FY22.

MANGALORE CHEMICALS Cash Flow Statement 2022-23

Particulars No. of months 12 12 % Change
Year Ending Mar-22 Mar-23
Cash Flow from Operating Activities Rs m -872 1,921 -
Cash Flow from Investing Activities Rs m -1,869 -2,430 -
Cash Flow from Financing Activities Rs m 4,038 -1,014 -
Net Cash Flow Rs m 1,297 -1,523 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for MANGALORE CHEMICALS

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 11.4, an improvement from the EPS of Rs 7.4 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 109.5, stands at 8.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 1.6 times, while the price to sales ratio stands at 0.4 times.
  • The company's price to cash flow (P/CF) ratio stood at 6.2 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Sales per share (Unadj.) Rs 244.3 307.2
TTM Earnings per share Rs 7.4 11.4
Diluted earnings per share Rs 7.4 11.4
Price to Cash Flow x 7.4 6.2
TTM P/E ratio x 11.7 8.0
Price / Book Value ratio x 1.4 1.5
Market Cap Rs m 9,698 12,115
Dividends per share (Unadj.) Rs 1.2 1.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for MANGALORE CHEMICALS

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.1x during FY23, from 1.0x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 2.7x during FY23, from 3.7x during FY22. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 16.8% during FY23, from 12.9% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 24.2% during FY23, from 20.4% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 9.0% during FY23, from 5.0% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Current ratio x 1.0 1.1
Debtors’ Days Days 838 759
Interest coverage x 3.7 2.7
Debt to equity ratio x 0.3 0.4
Return on assets % 5.0 9.0
Return on equity % 12.9 16.8
Return on capital employed % 20.4 24.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how MANGALORE CHEMICALS has performed over the last 5 years, please visit here.

MANGALORE CHEMICALS Share Price Performance

Over the last one year, MANGALORE CHEMICALS share price has moved down from Rs 123.2 to Rs 109.5, registering a loss of Rs 13.7 or around 11.1%.

Overall, the S&P BSE SENSEX is up 15.8% over the year.

(To know more, check out historical annual results for MANGALORE CHEMICALS and quarterly results for MANGALORE CHEMICALS)

Annual Report FAQs

What is the current share price of MANGALORE CHEMICALS?

MANGALORE CHEMICALS currently trades at Rs 117.3 per share. You can check out the latest share price performance of MANGALORE CHEMICALS here...

What was the revenue of MANGALORE CHEMICALS in FY23? How does it compare to earlier years?

The revenues of MANGALORE CHEMICALS stood at Rs 36,722 m in FY23, which was up 25.8% compared to Rs 29,199 m reported in FY22.

MANGALORE CHEMICALS' revenue has grown from Rs 30,857 m in FY19 to Rs 36,722 m in FY23.

Over the past 5 years, the revenue of MANGALORE CHEMICALS has grown at a CAGR of 4.4%.

What was the net profit of MANGALORE CHEMICALS in FY23? How does it compare to earlier years?

The net profit of MANGALORE CHEMICALS stood at Rs 1,347 m in FY23, which was up 53.3% compared to Rs 879 m reported in FY22.

This compares to a net profit of Rs 671 m in FY21 and a net profit of Rs 646 m in FY20.

Over the past 5 years, MANGALORE CHEMICALS net profit has grown at a CAGR of 42.3%.

What does the cash flow statement of MANGALORE CHEMICALS reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of MANGALORE CHEMICALS reveals:

  • Cash flow from operations increased in FY23 and stood at Rs 1,921 m as compared to Rs -872 m in FY22.
  • Cash flow from investments decreased in FY23 and stood at Rs -2,430 m as compared to Rs -1,869 m in FY22.
  • Cash flow from financial activity decreased in FY23 and stood at Rs -1,014 m as compared to Rs 4,038 m in FY22.

Here's the cash flow statement of MANGALORE CHEMICALS for the past 5 years.

(Rs m)FY19FY20FY21FY22FY23
From Operations-2,6186,2879,620-8721,921
From Investments-589-646-1,206-1,869-2,430
From Financial Activity2,496-3,927-7,0204,038-1,014
Net Cashflow-7101,7131,3941,297-1,523

What does the Key Ratio analysis of MANGALORE CHEMICALS reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of MANGALORE CHEMICALS reveals:

  • Operating profit margins witnessed a fall and down at 8.5% in FY23 as against 7.3% in FY22.
  • Net profit margins grew from 3.0% in FY22 to 3.7% in FY23.
  • Debt to Equity ratio for FY23 stood at 0.4 as compared to 0.3 in FY22.

Here's the ratio/financial analysis of MANGALORE CHEMICALS for the past 5 years.

 FY19FY20FY21FY22FY23
Operating Profit Margin (%)6.17.59.37.38.5
Net Profit Margin (%)1.12.43.13.03.7
Debt to Equity Ratio (x)0.50.40.20.30.4

 

Equitymaster requests your view! Post a comment on "MANGALORE CHEMICALS 2022-23 Annual Report Analysis". Click here!